Outsourcing

Articles

A RoTab tablet press can product up to 42,000 tablets per hour for Juniper Pharma Services.

Juniper Pharma Services Adds Tablet Press

The company expanded its topicals capacity with an investment in the Becomix RW30 model homogenizer.

Juniper Pharma Services Expands Topicals Capacity

Agnes Shanley is senior editor of Pharmaceutical Technology.

For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.

Keeping It Simple: Collaborating for Success in Drug Delivery

Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.

Catalent Reports Action to Restart Softgel Facility

Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.

GRAM Adds Board Member

In the past, contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) have been focused most on achieving scale, reaching new clients in new geographic regions, and adding services that were previously unavailable, according to Gil Y. Roth, president of the Pharma and Biopharma Outsourcing Association. In a new report from CPhI, Roth explicates how consolidation has changed how CMOs position their services to clients and how CMOs add value to their businesses.

How CMO Consolidation is Shaping the Manufacturing Industry

Vetter plans to invest approximately 300 million Euros during the course of five years to expand drug product manufacturing and logistic services in Germany; upgrades will include an improved RABS system for aseptic processing.

Vetter Embarks on 300-Million Euro Manufacturing Expansion

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

While all market signs are pointing up, memories of past setbacks may discourage from expanding capacity.

CDMOs Cautiously Address Expansion

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The 12th Annual Report and Survey of Biomanufacturing is now available.

BioPlan Associates Releases 2015 Edition of its Annual Survey

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Contract Manufacturing, Finished Drug Product